C012 New Innovations in Dermatology: What Devices you will be Using in the Next 1-5 Years
DESCRIPTION
This session will be devoted towards examining the cutting-edge changes to our practices in terms of treatments and technologies. This session will emphasize current and forward-looking “game changers” that will transform the delivery of dermatologic care for the benefit of our patients featuring the world leaders creating this innovation.
LEARNING OBJECTIVES
Discuss new treatments in dermatology.
Assess patient needs for new treatments in dermatology.
Predict new devices to become routine parts of clinical practice in the next 1-5 years.
SCHEDULE
1:00 PM
New Innovations in medical dermatology with devices in the next 5 years
Richard Rox Anderson, MD, FAAD
1:15 PM
New Innovations in neurotoxins and soft fillers in the next 5 years
Jeremy Green, MD, FAAD
1:30 PM
New innovations in the treatment and prevention on non-melanoma skin cancers in the next 1-5 years
Mathew M Avram, MD, JD, FAAD
1:35 PM
New innovations for the treatment of hair in the next 1-5 years
Marc R. Avram, MD, FAAD
1:40 PM
New Innovations in tissue tightening in the next 1-5 years
E. Victor Ross Jr., MD, FAAD
1:50 PM
Discussion
Mathew M Avram, MD, JD, FAAD, Richard Rox Anderson, MD, FAAD, Marc R. Avram, MD, FAAD, Jeremy Green, MD, FAAD
2:00 PM
New Innovations in fractional laser devices in the next 5 years
Roy G. Geronemus, MD, FAAD
2:15 PM
Finding, nurturing and funding innovation
Lynn A. Drake, MD, FAAD
2:25 PM
New Innovations for Treatment of Scars with Devices in the Next 1-5 years
David M Ozog, MD, FAAD
2:35 PM
New Innovations in treatment of vascular conditions with devices
Emil A. Tanghetti, MD, FAAD
2:45 PM
New Innovations in the Treatment of Acne with Devices
Fernanda H. Sakamoto, PhD, MD
2:55 PM
Discussion
Lynn A. Drake, MD, FAAD, Roy G. Geronemus, MD, FAAD, David M Ozog, MD, FAAD, Fernanda H. Sakamoto, PhD, MD, Emil A. Tanghetti, MD, FAAD
3:10 PM
New innovations in the treatment of subcutaneous and visceral fat in the next 1-5 years
Lilit Garibyan, PhD, MD, FAAD
3:20 PM
New innovations in the treatment of tattoos and pigment in the next 1-5 years
Eric F. Bernstein, MD, FAAD
3:30 PM
New Innovations for the treatment of body contouring and laxity
Suzanne L Kilmer, MD, FAAD
3:40 PM
New Innovations you weren't expecting over the next 1-5 years
Dieter Manstein, MD, PhD
3:50 PM
Discussion
Eric F. Bernstein, MD, FAAD, Lilit Garibyan, PhD, MD, FAAD, Suzanne L Kilmer, MD, FAAD, Dieter Manstein, MD, PhD
DIRECTOR
Mathew M Avram, MD, JD, FAAD
SPEAKERS
Richard Rox Anderson, MD, FAAD
Marc R. Avram, MD, FAAD
Eric F. Bernstein, MD, FAAD
Jean D.A. Carruthers, MD
Lynn A. Drake, MD, FAAD
Lilit Garibyan, PhD, MD, FAAD
Roy G. Geronemus, MD, FAAD
Jeremy Green, MD, FAAD
Suzanne L Kilmer, MD, FAAD
Dieter Manstein, MD, PhD
David M Ozog, MD, FAAD
E. Victor Ross Jr., MD, FAAD
Fernanda H. Sakamoto, PhD, MD
Emil A. Tanghetti, MD, FAAD
HANDOUTS
DISCLOSURES
Richard Rox Anderson, MD, FAAD
Accure Acne Inc. – Advisory Board(Stock); AVAVA, LLC – Advisory Board(Stock); Blossom Innovations, LLC – Founder(Stock); Brixton Biosciences – Founder(Stock); Cytrellis Biosystems, Inc – Advisory Board(Stock); Massachusetts General Hospital – Employee(Patent royalties or other compensation for Intellectual Property Rights); Sofregen Medical, Inc. – Consultant(Stock Options);
Marc R. Avram, MD, FAAD
No financial relationships exist with ineligible companies.
Mathew M Avram, MD, JD, FAAD
Allergan, Inc – Consultant (1099 relationship)(Fees); Cytrellis Biosystems, Inc – Consultant(Stock), Consultant(Stock Options); La Jolla NanoMedical – Consultant (1099 relationship)(Stock Options); Masters of Aesthetics, Inc. – Founder(Fees); Sofwave – Consultant (1099 relationship)(Stock Options);
Eric F. Bernstein, MD, FAAD
Acclaro Medical – Founder(Stock Options), Investigator(Equipment), Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Stock Options), Investigator(Grants/Research Funding); Cynosure, Inc. – Consultant(Stock Options); Joylux – Advisory Board(Stock Options); Novoxel – Advisory Board(Stock Options); Remedly, Inc – Advisory Board(Stock Options);
Jean D.A. Carruthers, MD
Alastin Skincare, Inc – Consultant(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Investigator(Grants/Research Funding); Bonti – Consultant(No Compensation Received); Fount Bio – Consultant (1099 relationship)(No Compensation Received); In Mode – Consultant (1099 relationship)(Grants/Research Funding); Kythera – Consultant(Honoraria); Kythera Biopharmaceuticals – Investigator(Honoraria); Merz Aesthetics – Consultant(Honoraria), Investigator(Honoraria); Revance Therapeutics, Inc. – Investigator(Honoraria);
Lynn A. Drake, MD, FAAD
No financial relationships exist with ineligible companies.
Lilit Garibyan, PhD, MD, FAAD
Aditum Bio – Consultant(Fees); Aegle Therapeutics – Advisory Board(Fees); Brixton Biosciences – Consultant(Fees), Stockholder(Stock); Clarity Cosmetics, Inc. – Other(No Compensation Received); EyeCool – Stockholder(Stock Options); Procter & Gamble Company – Consultant(Fees); Sante Ventures – Consultant(Fees); Vyome Therapeutics Limited – Advisory Board(Fees);
Roy G. Geronemus, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Cynosure, Inc – Investigator(Grants/Research Funding); Cytrellis Biosystems, Inc – Advisory Board(Grants/Research Funding), Investigator(Stock), Stockholder(Stock); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);
Jeremy Green, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amplifica – Investigator(Grants/Research Funding); Appiell Inc. – Advisory Board(Stock Options); Candesant Biomedical, Inc. – Investigator(Grants/Research Funding), Stockholder(Stock); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Evolus, Inc. – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma USA – Advisory Board(Honoraria); L'Oréal Research and Innovation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Revelle Aesthetics, Inc. – Advisory Board(Honoraria), Advisory Board(Stock Options), Investigator(Grants/Research Funding); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding);
Suzanne L Kilmer, MD, FAAD
Acclaro Medical – Advisory Board(Grants/Research Funding); Accure Medical, LLC – Stockholder(Stock); Allergan, Inc – Advisory Board(Grants/Research Funding); AVAVA, LLC – Stockholder(No Compensation Received); Avita – Investigator(Grants/Research Funding); Blueberry – Stockholder(Stock); BTL Industries – Advisory Board(Grants/Research Funding); Candescent Partners – Consultant(Honoraria); Cutera, Inc. – Investigator(Grants/Research Funding); Cynosure, Inc. – Investigator(Grants/Research Funding); Cytrellis Biosystems, Inc – Advisory Board(Grants/Research Funding); Dominion Aesthetics – Investigator(Honoraria); Endo Pharmaceuticals – Advisory Board(Grants/Research Funding); Engage Technologies – Stockholder(Stock); Evolus, Inc. – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); InMode – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); Lutronics, Inc. – Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); Miramar Labs – Advisory Board(Honoraria); Pulse Biosciences – Advisory Board(Grants/Research Funding); R2 Dermatology, Inc. – Investigator(Grants/Research Funding); Sciton Inc. – Advisory Board(Grants/Research Funding); Sienna Labs, Inc. – Advisory Board(Honoraria); Sofwave – Consultant(Grants/Research Funding); Solta Medical – Investigator(Grants/Research Funding); Solta Medical Inc – Advisory Board(No Compensation Received); Syneron Candela – Advisory Board(Grants/Research Funding); Venus Concepts – Advisory Board(Grants/Research Funding);
Dieter Manstein, MD, PhD
AVAVA, LLC – Consultant(Honoraria); Avava, LLC – Stockholder(Stock); Blossom Innovations, LLC – Stockholder(Stock); GME German Medical Engineering GmbH – Stockholder(Stock); R2 Dermatology, Inc. – Consultant(Honoraria), Other(Patent royalties or other compensation for Intellectual Property Rights); Soltego – Other(Stock); Syneron Candela – Other(Patent royalties or other compensation for Intellectual Property Rights); Zeltiq Aesthetics – Other(Patent royalties or other compensation for Intellectual Property Rights);
David M Ozog, MD, FAAD
Biofrontera AG – Investigator(Grants/Research Funding); Cutera – Investigator(Equipment); Galderma USA – Investigator(Grants/Research Funding); Michelson Diagnostics – Investigator(Grants/Research Funding); miRagen Therapeutics, Inc. – Investigator(Grants/Research Funding); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sciton, Inc. – Investigator(Equipment);
E. Victor Ross Jr., MD, FAAD
Benev – Consultant(Honoraria); Cutera, Inc. – Investigator(Equipment); laser optek – Other(Honoraria); laseroptek – Other(Honoraria); Lumenis – Investigator(Equipment), Investigator(Honoraria); Lutronic – Consultant(Honoraria); Venus Concept – Investigator(Grants/Research Funding);
Fernanda H. Sakamoto, PhD, MD
Accure Medical, LLC – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); AVAVA, LLC – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Beiersdorf, Inc. – Advisory Board(Honoraria); Blossom Innovations, LLC – Founder(Patent royalties or other compensation for Intellectual Property Rights); Cytrellis Biosystems, Inc – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Follica – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Lightwater Biosciences, Inc. – Advisory Board(No Compensation Received), Advisory Board(Stock Options); R2 Dermatology, Inc. – Advisory Board(Stock); Seventh Sense BioSystems – Advisory Board(Stock); Sofregen Medical, Inc. – Advisory Board(Stock);
Emil A. Tanghetti, MD, FAAD
AbbVie – Speaker(Honoraria); Accure Medical, LLC – Investigator(Grants/Research Funding); Accure, Inc – Stockholder Private Company(Stock Options); Aesthetics Biomedical – Advisory Board(Other Financial Benefit); Arcutis Biotherapeutics – Advisory Board(Honoraria), Speaker(Honoraria); Cynosure, Inc. – Consultant(Equipment), Investigator(Equipment); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly and Company – Speaker(Honoraria); Galderma Research & Development, LLC – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Speaker(Honoraria); Lutronic – Advisory Board(Equipment); Ortho Dermatologics – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Quanta System S.p.A – Consultant(Equipment);